Immuneering (IMRX) Net Margin (2020 - 2022)
Immuneering (IMRX) posted quarterly Net Margin of 2988714.95% for Q4 2022, down 298291233.0% year-over-year from N/an in Q4 2021, and down 2852.28% quarter-over-quarter from 101234.04% in Q3 2022.
Analysis
Immuneering (IMRX) Net Margin (2020 - 2022) Analysis & Trends
Immuneering's Net Margin history runs 3 years deep, the most recent figure standing at 2988714.95% for Q4 2022.
- In Q4 2022, Net Margin fell 298291233.0% year-over-year to 2988714.95%; the TTM figure through Sep 2023 stood at 19339544.84% (down 1932229148.0% YoY), while the FY2022 annual figure was 15937.29%, down 1432497.0% from the prior year.
- Net Margin for Q4 2022 stood at 2988714.95%, down from 101234.04% in the prior quarter.
- The five-year high for Net Margin was 646.07% in Q3 2020, with the low at 2988714.95% in Q4 2022.
- The 3-year median for Net Margin is 5802.62% (2021), against an average of 285967.89%.
- The sharpest annual moves came in 2021 and 2022: Net Margin tumbled 221025 bps in 2021, then tumbled 298291233 bps in 2022.
- Immuneering's Net Margin stood at 881.43% in 2020, then tumbled by 558 bps to 5802.62% in 2021, then sank by 51406 bps to 2988714.95% in 2022.
- Business Quant data shows IMRX's Net Margin at 2988714.95% in Q4 2022, 101234.04% in Q3 2022, and 20525.33% in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Immuneering | 313.13 Mn | 313.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -2,960,184.40% |
| Sep 30, 2022 | -33,781.04% |
| Jun 30, 2022 | -12,183.19% |
| Mar 31, 2022 | -6,964.23% |
| Dec 31, 2021 | -5,787.65% |
| Sep 30, 2021 | -1,768.40% |
| Jun 30, 2021 | -1,210.18% |
| Mar 31, 2021 | -832.62% |
| Dec 31, 2020 | -877.48% |
| Sep 30, 2020 | -644.49% |
| Jun 30, 2020 | -749.56% |